Home

Schäbig Schmiede Präambel roscovitine mechanism of action Übernehmen Erhebe dich Starker Wind

Roscovitine - CAS 186692-46-6 - Calbiochem A potent, reversible, and  selective inhibitor of Cdks that exhibits
Roscovitine - CAS 186692-46-6 - Calbiochem A potent, reversible, and selective inhibitor of Cdks that exhibits

Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome -  ScienceDirect
Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome - ScienceDirect

From Roscovitine to CYC202 to Seliciclib – from bench to bedside: discovery  and development
From Roscovitine to CYC202 to Seliciclib – from bench to bedside: discovery and development

R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal  Muscular Atrophy - ScienceDirect
R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy - ScienceDirect

Seliciclib - Wikipedia
Seliciclib - Wikipedia

New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy:  Trends in Cell Biology
New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy: Trends in Cell Biology

Roscovitine induces up-regulation of both pro-and antiapoptotic BCL-2... |  Download Scientific Diagram
Roscovitine induces up-regulation of both pro-and antiapoptotic BCL-2... | Download Scientific Diagram

Frontiers | Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic  Cancers | Oncology
Frontiers | Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers | Oncology

Cells | Free Full-Text | Cellular and Molecular Mechanisms of R/S- Roscovitine and CDKs Related Inhibition under Both Focal and Global  Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells | HTML
Cells | Free Full-Text | Cellular and Molecular Mechanisms of R/S- Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells | HTML

Cyclin-dependent kinase inhibitors in brain cancer: current state and  future directions
Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions

Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis  patients chronically infected with Pseudomonas aeruginosa, a randomized,  placebo-controlled study - Journal of Cystic Fibrosis
Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study - Journal of Cystic Fibrosis

Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential  Therapeutic Opportunity in Cystic Fibrosis. - Abstract - Europe PMC
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis. - Abstract - Europe PMC

Frontiers | Inflammation Resolution and the Induction of Granulocyte  Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs | Pharmacology
Frontiers | Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs | Pharmacology

An in silico exploration of the interaction mechanism of  pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors - Molecular BioSystems (RSC  Publishing) DOI:10.1039/C3MB70186G
An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors - Molecular BioSystems (RSC Publishing) DOI:10.1039/C3MB70186G

Structural analogues of roscovitine rescue the intracellular traffic and  the function of ER-retained ABCB4 variants in cell models | Scientific  Reports
Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models | Scientific Reports

Roscovitine (Seliciclib,CYC202) | CAS:186692-46-6 | CDK inhibitor,potent  and selective | High Purity | Manufacturer BioCrick
Roscovitine (Seliciclib,CYC202) | CAS:186692-46-6 | CDK inhibitor,potent and selective | High Purity | Manufacturer BioCrick

Roscovitine has anti-proliferative and pro-apoptotic effects on  glioblastoma cell lines: A pilot study
Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study

Model depicting mechanism of action of R-Roscovitine and its inhibition...  | Download Scientific Diagram
Model depicting mechanism of action of R-Roscovitine and its inhibition... | Download Scientific Diagram

Hypothetic scheme of cell death induction pathway triggered roscovitine...  | Download Scientific Diagram
Hypothetic scheme of cell death induction pathway triggered roscovitine... | Download Scientific Diagram

Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against  influenza a virus replication - ScienceDirect
Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication - ScienceDirect

Mechanism of action of novel medical treatments for Cushing's disease.... |  Download Scientific Diagram
Mechanism of action of novel medical treatments for Cushing's disease.... | Download Scientific Diagram

Schematic diagram depicting the effects of roscovitine in granule... |  Download Scientific Diagram
Schematic diagram depicting the effects of roscovitine in granule... | Download Scientific Diagram

Roscovitine attenuates intimal hyperplasia via inhibiting NF-κB and STAT3  activation induced by TNF-α in vascular smooth muscle cells - ScienceDirect
Roscovitine attenuates intimal hyperplasia via inhibiting NF-κB and STAT3 activation induced by TNF-α in vascular smooth muscle cells - ScienceDirect

The binding pockets and interaction mechanisms of roscovitine in free... |  Download Scientific Diagram
The binding pockets and interaction mechanisms of roscovitine in free... | Download Scientific Diagram

Dr. Pankaj Shah Prof&HOD Department of nephrolgy &Transplant Medicine  Prevention of cyst progression in Autosomal dominant polycystic kidney  disease. - ppt download
Dr. Pankaj Shah Prof&HOD Department of nephrolgy &Transplant Medicine Prevention of cyst progression in Autosomal dominant polycystic kidney disease. - ppt download

Frontiers | CDK9 as a Valuable Target in Cancer: From Natural Compounds  Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas |  Pharmacology
Frontiers | CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas | Pharmacology